Insulet Corp (PODD)

$332.70 +0.03 (0.01%)
Market Cap 23.40B
Revenue (ttm) 2.07B
Net Income (ttm) 418.30M
EPS (ttm) N/A
PE Ratio 72.64
Forward PE 68.08
Profit Margin 20.19%
Debt to Equity Ratio 0.73
Volume 405,800
Avg Vol 591,556
Day's Range N/A - N/A
Shares Out 70.35M
Stochastic %K 84%
Beta 1.39
Analysts Strong Sell
Price Target $376.17

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
HedgeAlerts
HedgeAlerts Nov. 16 at 10:43 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $330.00 Put · NOV 21, 2025 Exp Entry Price: $7.50 - $11.80 Exit Price Target: $16.12 Profit Margin: +115% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 16 at 12:58 AM
💎 LiquidTheta® Live Actionable Trade Asset: $PODD Contracts: $PODD June 18, 2026 $340 Calls Scale in: $33.67- $41.16 Scale out: $130.95-$224.49 Profit Potential : 309% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 15 at 10:45 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $330.00 Put · NOV 21, 2025 Exp Entry Price: $7.50 - $11.80 Exit Price Target: $16.12 Profit Margin: +115% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 15 at 12:31 AM
💎 LiquidTheta® Live Actionable Trade Asset: $PODD Contracts: $PODD June 18, 2026 $340 Calls Scale in: $33.97- $41.51 Scale out: $132.09-$226.44 Profit Potential : 190% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:28 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $330.00 Put · NOV 21, 2025 Exp Entry Price: $7.50 - $8.50 Exit Price Target: $10.12 Profit Margin: +35% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:48 AM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $330.00 Put · NOV 21, 2025 Exp Entry Price: $7.50 - $9.60 Exit Price Target: $12.07 Profit Margin: +61% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
gti10001
gti10001 Nov. 13 at 4:01 PM
Insulet ($PODD ) pumps up medtech gains! Strong Buy flip – $400.50 target from $336.84. 19% upside rocket! Diabetes innovators, strap in. #PODD #MedTechBoom #GTINDICATORS
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 2:30 PM
$PODD smashes Q3 expectations — is it set for more growth? 🚀 🔹 EPS of $1.24 beats estimates by 9.73% 🔹 Revenue of $706.3M up 29.9% YoY at CER 🔹 Total Omnipod sales surge 31%, international demand strong Discover the full story behind Insulet's impressive quarter 👉 https://www.zacks.com/stock/news/2790413/insulet-stock-up-post-q3-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2790413-body-20854&ADID=SYND_STOCKTWITS_TWEET_2_2790413_BODY_20854
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 1:21 PM
$PODD pops after a clean Q3 beat 📈 Earnings and revenue both topped expectations, and expanding margins signal stronger operational leverage heading into next quarter. Full breakdown of what’s driving the upside 👉 https://www.zacks.com/stock/news/2790413/insulet-stock-up-post-q3-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2790413-teaser-20817&ADID=SYND_STOCKTWITS_TWEET_2_2790413_TEASER_20817
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 10:43 AM
BTIG has adjusted their stance on Insulet ( $PODD ), setting the rating to Buy with a target price of 370.
0 · Reply
Latest News on PODD
PODD Vs. Intuitive Surgical: This Underdog Might Just Win

Nov 12, 2025, 2:15 PM EST - 4 days ago

PODD Vs. Intuitive Surgical: This Underdog Might Just Win

ISRG

Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 12:46 PM EST - 10 days ago

Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript

Insulet tops quarterly estimates on demand for wearable insulin pumps

Nov 6, 2025, 7:29 AM EST - 10 days ago

Insulet tops quarterly estimates on demand for wearable insulin pumps

Insulet Reports Third Quarter 2025 Results

Nov 6, 2025, 6:30 AM EST - 10 days ago

Insulet Reports Third Quarter 2025 Results

Final Trades: Insulet Corp, Uber and Apollo Global

Nov 4, 2025, 1:20 PM EST - 12 days ago

Final Trades: Insulet Corp, Uber and Apollo Global

APO UBER

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Oct 30, 2025, 4:00 AM EDT - 18 days ago

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

10 stocks primed for growth in the S&P 500's cheapest sectors

Oct 23, 2025, 11:29 AM EDT - 24 days ago

10 stocks primed for growth in the S&P 500's cheapest sectors

BX AJG APO BRO DXCM FITB HOOD

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

Oct 23, 2025, 7:00 AM EDT - 24 days ago

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

Insulet to Host Investor Day on November 20, 2025

Oct 10, 2025, 7:00 AM EDT - 5 weeks ago

Insulet to Host Investor Day on November 20, 2025

These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process

Sep 22, 2025, 10:19 AM EDT - 7 weeks ago

These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process

ADI BA CCL COIN DASH NUE NVDA

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Sep 18, 2025, 7:00 AM EDT - 2 months ago

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Medical device maker Insulet names industry veteran Flavia Pease as CFO

Sep 16, 2025, 7:25 AM EDT - 2 months ago

Medical device maker Insulet names industry veteran Flavia Pease as CFO

Insulet Announces CFO Transition

Sep 16, 2025, 7:00 AM EDT - 2 months ago

Insulet Announces CFO Transition

Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 2:31 PM EDT - 2 months ago

Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript

Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 4, 2025, 6:33 PM EDT - 2 months ago

Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Insulet Elevates Eric Benjamin to Chief Operating Officer

Aug 25, 2025, 5:00 PM EDT - 2 months ago

Insulet Elevates Eric Benjamin to Chief Operating Officer

Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV

Aug 19, 2025, 1:20 PM EDT - 3 months ago

Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV

CSCO RKT IGV

Insulet to Participate in Upcoming Investor Conferences

Aug 19, 2025, 6:00 AM EDT - 3 months ago

Insulet to Participate in Upcoming Investor Conferences

20 stocks in the S&P 500 that are high achievers this earnings season

Aug 15, 2025, 8:52 AM EDT - 3 months ago

20 stocks in the S&P 500 that are high achievers this earnings season

ANET APH COIN CTRA EQT EXE FICO

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Aug 13, 2025, 11:49 PM EDT - 3 months ago

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Aug 7, 2025, 1:08 PM EDT - 3 months ago

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 11:14 AM EDT - 3 months ago

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Insulet beats second-quarter profit estimates on strong demand for insulin pumps

Aug 7, 2025, 8:39 AM EDT - 3 months ago

Insulet beats second-quarter profit estimates on strong demand for insulin pumps

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

Aug 7, 2025, 7:00 AM EDT - 3 months ago

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

Jul 31, 2025, 9:52 AM EDT - 3 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM EW ISRG LLY SYK

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

Jul 21, 2025, 10:27 AM EDT - 4 months ago

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

CMG COF DXCM FSLR INTU LLY MA

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Jul 8, 2025, 6:00 AM EDT - 4 months ago

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Jun 19, 2025, 6:00 AM EDT - 5 months ago

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

20 stocks bucking bad trends on Wall Street — what might be next for them?

Jun 10, 2025, 10:53 AM EDT - 5 months ago

20 stocks bucking bad trends on Wall Street — what might be next for them?

AMT ANET AVGO BSX TRMB BAC C

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

Jun 10, 2025, 8:30 AM EDT - 5 months ago

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

20 stocks of companies that have improved profit margins and are expected to grow quickly

Jun 9, 2025, 9:28 AM EDT - 5 months ago

20 stocks of companies that have improved profit margins and are expected to grow quickly

AMD AVGO CSGP DASH ENPH FICO FTNT

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 23, 2025, 6:01 AM EDT - 6 months ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Outlier Money Flows Lift Insulet

May 14, 2025, 7:20 AM EDT - 6 months ago

Outlier Money Flows Lift Insulet

Insulet Announces Publication of 2024 Sustainability Report

May 13, 2025, 6:00 AM EDT - 6 months ago

Insulet Announces Publication of 2024 Sustainability Report

20 stocks of companies showing excellent earnings-season trends even as the economy cools

May 12, 2025, 11:18 AM EDT - 6 months ago

20 stocks of companies showing excellent earnings-season trends even as the economy cools

AMD APH CF CTRA DVN ENPH EQT

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

May 9, 2025, 6:31 PM EDT - 6 months ago

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

May 9, 2025, 12:31 PM EDT - 6 months ago

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

MNST TSLA

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

May 9, 2025, 11:05 AM EDT - 6 months ago

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

Insulet Is the Top S&P 500 Performer Today. Here's Why.

May 9, 2025, 10:11 AM EDT - 6 months ago

Insulet Is the Top S&P 500 Performer Today. Here's Why.

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:35 PM EDT - 6 months ago

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

Insulet beats quarterly profit estimates on insulin pump demand

May 8, 2025, 4:28 PM EDT - 6 months ago

Insulet beats quarterly profit estimates on insulin pump demand

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

May 8, 2025, 4:01 PM EDT - 6 months ago

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)

Insulet Names New CEO, Expects to Top Revenue Projections

Apr 28, 2025, 10:26 AM EDT - 7 months ago

Insulet Names New CEO, Expects to Top Revenue Projections

Insulet Appoints Ashley McEvoy President and CEO

Apr 28, 2025, 6:00 AM EDT - 7 months ago

Insulet Appoints Ashley McEvoy President and CEO

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Apr 3, 2025, 6:00 AM EDT - 8 months ago

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Mar 19, 2025, 4:01 PM EDT - 8 months ago

Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Insulet Announces Pricing of Senior Notes Due 2033

Mar 18, 2025, 4:32 PM EDT - 8 months ago

Insulet Announces Pricing of Senior Notes Due 2033

Insulet Announces Proposed Financing Transactions

Mar 18, 2025, 7:35 AM EDT - 8 months ago

Insulet Announces Proposed Financing Transactions

Insulet Leans Bullish (Technical Analysis)

Mar 17, 2025, 11:53 PM EDT - 8 months ago

Insulet Leans Bullish (Technical Analysis)

Insulet to Host Investor Day on June 5, 2025

Mar 11, 2025, 6:00 AM EDT - 8 months ago

Insulet to Host Investor Day on June 5, 2025

HedgeAlerts
HedgeAlerts Nov. 16 at 10:43 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $330.00 Put · NOV 21, 2025 Exp Entry Price: $7.50 - $11.80 Exit Price Target: $16.12 Profit Margin: +115% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 16 at 12:58 AM
💎 LiquidTheta® Live Actionable Trade Asset: $PODD Contracts: $PODD June 18, 2026 $340 Calls Scale in: $33.67- $41.16 Scale out: $130.95-$224.49 Profit Potential : 309% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 15 at 10:45 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $330.00 Put · NOV 21, 2025 Exp Entry Price: $7.50 - $11.80 Exit Price Target: $16.12 Profit Margin: +115% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 15 at 12:31 AM
💎 LiquidTheta® Live Actionable Trade Asset: $PODD Contracts: $PODD June 18, 2026 $340 Calls Scale in: $33.97- $41.51 Scale out: $132.09-$226.44 Profit Potential : 190% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:28 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $330.00 Put · NOV 21, 2025 Exp Entry Price: $7.50 - $8.50 Exit Price Target: $10.12 Profit Margin: +35% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:48 AM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $330.00 Put · NOV 21, 2025 Exp Entry Price: $7.50 - $9.60 Exit Price Target: $12.07 Profit Margin: +61% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
gti10001
gti10001 Nov. 13 at 4:01 PM
Insulet ($PODD ) pumps up medtech gains! Strong Buy flip – $400.50 target from $336.84. 19% upside rocket! Diabetes innovators, strap in. #PODD #MedTechBoom #GTINDICATORS
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 2:30 PM
$PODD smashes Q3 expectations — is it set for more growth? 🚀 🔹 EPS of $1.24 beats estimates by 9.73% 🔹 Revenue of $706.3M up 29.9% YoY at CER 🔹 Total Omnipod sales surge 31%, international demand strong Discover the full story behind Insulet's impressive quarter 👉 https://www.zacks.com/stock/news/2790413/insulet-stock-up-post-q3-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2790413-body-20854&ADID=SYND_STOCKTWITS_TWEET_2_2790413_BODY_20854
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 1:21 PM
$PODD pops after a clean Q3 beat 📈 Earnings and revenue both topped expectations, and expanding margins signal stronger operational leverage heading into next quarter. Full breakdown of what’s driving the upside 👉 https://www.zacks.com/stock/news/2790413/insulet-stock-up-post-q3-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2790413-teaser-20817&ADID=SYND_STOCKTWITS_TWEET_2_2790413_TEASER_20817
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 10:43 AM
BTIG has adjusted their stance on Insulet ( $PODD ), setting the rating to Buy with a target price of 370.
0 · Reply
NJgolfer
NJgolfer Nov. 13 at 3:17 AM
$PODD another buy signal stock today and not surprised it is in the health tech sector. RSI above 58, Chaikin MF turned positive as well
0 · Reply
NJgolfer
NJgolfer Nov. 13 at 3:15 AM
$PODD
0 · Reply
Iightning
Iightning Nov. 11 at 6:46 PM
1ightning® Options Trade Alert (Actionable) | Buy $PODD Nov 21 $330 Call | Enter: $8.05 Exit: $9.91 | Profit: 23.07% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 9 at 6:55 PM
1ightning® Options Trade Alert (Actionable) | Buy $PODD Nov 21 $320 Call | Enter: $19.00 Exit: $28.14 | Profit: 48.11% ROI | https://1ightning.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 9 at 1:46 AM
💎 LiquidTheta® Live Actionable Trade Asset: $PODD Contracts: $PODD June 18, 2026 $320 Calls Scale in: $42.10- $51.45 Scale out: $163.71-$280.65 Profit Potential : 342% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 10:04 PM
Canaccord Genuity has updated their rating for Insulet ( $PODD ) to Buy with a price target of 428.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 7:08 PM
RBC Capital has adjusted their stance on Insulet ( $PODD ), setting the rating to Outperform with a target price of 365 → 370.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:45 PM
Wells Fargo has adjusted their stance on Insulet ( $PODD ), setting the rating to Overweight with a target price of 350 → 360.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 5:48 PM
UBS updates rating for Insulet ( $PODD ) to Neutral, target set at 320 → 355.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 4:31 PM
Truist Securities updates rating for Insulet ( $PODD ) to Buy, target set at 365 → 390.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 3:27 PM
Barclays has adjusted their stance on Insulet ( $PODD ), setting the rating to Equal-Weight with a target price of 301 → 316.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 7 at 3:01 PM
$PODD RSI: 58.91, MACD: -0.2592 Vol: 5.51, MA20: 320.04, MA50: 325.87 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply